Rasna Therapeutics Inc. — Form D

Rasna Therapeutics Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2016-12-22. The offering totals $10.0M, of which $2.0M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2016-12-22
• Form: D
• Accession: 0001144204-16-141020
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $10.0M
• Amount sold: $2.0M
• Remaining: $8.0M
• Minimum investment: $25K
• Investors: 5
• Date of first sale: 2016-12-20
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-276930

Issuer

• Name: Rasna Therapeutics Inc.
• CIK: 0001582249
• Entity type: Corporation
• Jurisdiction: NEVADA
• Incorporated: 2012
• Address: 420 LEXINGTON AVENUE, NEW YORK, NY, 10170
• Phone: 646-396-4087

Officers, directors & promoters (9)

More

• CIK 1582249 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search